Accurately assessing congenital heart disease using artificial intelligence

Khalil Khan1, Farhan Ullah2, Ikram Syed3

  • 1Department of Computer Science, School of Engineering and Digital Sciences, Nazarbayev University, Astana, Kazakhstan.

Peerj. Computer Science
|December 9, 2024
PubMed

Insights

Machine learning (ML) models offer improved accuracy in predicting congenital heart disease (CHD) mortality risk. This review analyzes ML methods, datasets, and future directions for enhanced CHD diagnosis and care.

Area of Science:

  • Medical Informatics
  • Artificial Intelligence in Healthcare
  • Cardiology

Background:

  • Congenital heart disease (CHD) is a major cause of newborn mortality, especially in low-resource settings.
  • Limited healthcare resources exacerbate the impact of CHD globally.
  • Accurate risk assessment and early diagnosis are critical for improving infant outcomes.

Purpose of the Study:

  • To provide a comprehensive analysis of machine learning (ML) methods for CHD diagnosis over the past eight years.
  • To describe available datasets for CHD research and their relevance to ML applications.
  • To critically evaluate existing ML algorithms, their strengths, weaknesses, and limitations in CHD identification.

Main Methods:

  • Systematic review and analysis of ML techniques applied to CHD diagnosis.
  • Evaluation of various datasets used in CHD research, including data collection and characteristics.
  • Critical assessment of the performance and limitations of current ML algorithms for CHD.

Main Results:

  • ML models show significant potential in accurately assessing CHD mortality risk.
  • ML algorithms enhance diagnostic accuracy by identifying complex patterns often missed by clinicians.
  • A review of ML methods, datasets, and algorithms provides insights into current capabilities and challenges.

Conclusions:

  • ML offers a promising avenue for improving the identification and management of CHD.
  • Further research is needed to fully leverage ML's potential in CHD diagnosis and treatment.
  • Future directions focus on enhancing the efficacy of ML for better infant outcomes in CHD cases.

Related Concept Videos